Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

981
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
981
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

435
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
435
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

606
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
606
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

873
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
873
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers01:25

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

766
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
766
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

856
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
856

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Difficult Conversation Case: Death Notification.

Journal of education & teaching in emergency medicine·2026
Same author

Clinical Decision-Making Case: Thyroid Storm.

Journal of education & teaching in emergency medicine·2026
Same author

Procedural case: Ultrasound Case: Syncope in PE.

Journal of education & teaching in emergency medicine·2026
Same author

Managing Conflict Case: The Difficult Consultant.

Journal of education & teaching in emergency medicine·2026
Same author

Reassessment Case: Acute Pulmonary Edema in a Boarding Patient.

Journal of education & teaching in emergency medicine·2026
Same author

Enhancing Emergency Medicine Training Through Trauma-Informed Pelvic Exam Education.

Cureus·2025
Same journal

Woman with a Blackened Tongue: A Case Report.

Journal of education & teaching in emergency medicine·2026
Same journal

A Case Report on an Open Fracture Dislocation Injury of the Proximal Phalanx of the Thumb Resulting from Playing Cricket.

Journal of education & teaching in emergency medicine·2026
Same journal

Escape Intern Orientation! - A Capstone and Team Building Activity for New EM Interns.

Journal of education & teaching in emergency medicine·2026
Same journal

A Novel Low-Cost Phantom for Ultrasound-Guided Fascia Iliaca Nerve Blocks.

Journal of education & teaching in emergency medicine·2026
Same journal

The Rash That Didn't Blanch: A Case Report of Adult-Onset IgA Vasculitis with Underlying Cirrhosis and IgA Nephropathy.

Journal of education & teaching in emergency medicine·2026
Same journal

Low-Cost, Reusable Fracture Reduction Task Trainer for Distal Radius Fractures.

Journal of education & teaching in emergency medicine·2026
查看所有相关文章

相关实验视频

Updated: Sep 12, 2025

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

3.6K

贝塔抑制剂的毒性 贝塔抑制剂的毒性

Amrita Vempati1, P J Greene1

  • 1Creighton University School of Medicine Phoenix Program, Valleyhealth Medical Center, Department of Emergency Medicine, Phoenix, AZ.

Journal of education & teaching in emergency medicine
|August 6, 2025
PubMed
概括
此摘要是机器生成的。

这种模拟有效地训练了紧急医疗人员来管理β-阻断剂 (BB) 毒性,提高了治疗低血压和心的信心. 参与者报告说,在高准确度模拟和汇报后,医疗知识和患者护理技能得到了增强.

更多相关视频

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
14:03

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

2.0K
Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

1.9K

相关实验视频

Last Updated: Sep 12, 2025

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

3.6K
High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
14:03

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on: March 24, 2023

2.0K
Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

1.9K

科学领域:

  • 医学教育 医学教育
  • 紧急医疗 紧急医疗
  • 毒理学 毒理学 毒理学

背景情况:

  • β-阻断剂 (BB) 毒性是致命事故的重要原因,呈现出严重的心血管症状,如低血压和胆心梗塞.
  • 紧急医疗医生需要掌握管理BB过量剂量的能力,因为其具有关键性质,并且在急诊室经常出现.
  • 有效的培训对EM住院人员至关重要,以自信地管理BB毒性,包括复杂的耐火性低血压病例.

研究的目的:

  • 评估高保真模拟在教育紧急医疗 (EM) 住院人员管理β-阻断剂 (BB) 毒性的有效性.
  • 评估基于模拟的培训对学习者对管理不分化的低血压和BB过量剂量的信心的影响.
  • 加强关键的管理概念,包括低血糖症,胸肌梗塞,血管压缩剂的使用,以及特定的BB毒性治疗.

主要方法:

  • 对第一年EM居民进行了一次高准确度模拟会议,随后进行了汇报.
  • 参与者被分为主动管理和观察组,以管理模拟的BB过量病例.
  • 会议后的在线调查使用利克特级别评估案例可信度,复杂性,学习效率和信心水平.

主要成果:

  • 十位调查受访者都同意或强烈同意,仿真增强了学习,医学知识和患者护理技能.
  • 参与者报告说,在模拟和汇报后,他们对管理不加区分的低血压和BB毒性的信心增加了.
  • 模拟有效地加强了诸如低血糖治疗,心管理,血管压缩剂和特定BB毒性干预措施的使用等概念.

结论:

  • 高保真模拟提供了一个有效的平台,用于培训EM住院人员管理β-阻断剂毒性.
  • 这种教育方法显著提高了学习者在处理临界低血压和过量情况时的信心和能力.
  • 基于模拟的学习加强了对危及生命的毒理紧急情况的基本临床技能和治疗算法.